Glenmark Pharmaceuticals is introducing travoprost ophthalmic solution, 0.004% (ionic buffered solution), which is the generic of Sandoz’s Travatan Z. The medication is indicated for glaucoma and ...
Travoprost Ophthalmic Solution, 0.004%, is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Lupin has received approval from ...
ZURICH, Dec 23 (Reuters) - Swiss pharmaceutical group Novartis said on Tuesday the European Commission had approved an additional treatment for its eyecare unit Alcon's Travatan treatment for glaucoma ...
Alcon, Inc., a leading eye care company, reported that it has reached a global settlement with Pharmacia Corporation on all intellectual property disputes involving Alcon's newest anti-glaucoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results